Programme 

Fee

Eligibility 

COVID 19 Adverse Event

$69.00 (incl.GST)
Standard Consult - Virtual Assessment

$138.00 (incl. GST)
Complex Consult -
In-Person Assessment

Eligibility

• Patient must have had an adverse event to the vaccine.

• CARM (Centre for Adverse Reactions Monitoring) form must be completed.

• Observations are required for full assessments.

• Full assessments can only be performed by a Nurse Practitioner or GP.

If there is any suspicion that the adverse event may have been caused by the COVID-19 vaccination, please report to CARM here.

Key Information

• Report any concerning, or serious, event or reaction following immunisation.

• Discuss future immunisations and carefully consider any reactions to a previous vaccine dose. If in doubt about safety, seek specialist advice.  

COVID 19 Care in the Community - Advanced Prescriptions for Therapeutics

$103.50 (incl. GST)
Initial Consult - Prescription Issued

$69.00 (incl. GST)
Initial Consult - No Prescriptions Issued

$51.75 (incl. GST)
Prescription Re-Issued - After Initial Prescription Expired

Eligibility

To be eligible the patient must:

• Have COVID-19 and symptoms or be a Household Contact and have symptoms; and

• Been sick within the last 5 days; and

• Meet one of the additional antiviral eligibility criteria. 

Exclusions

• Claiming is limited to one type of claim per person, per day, per practice.

• No simultaneous claiming against other funding streams, this includes claims for COVID-19 Community Care Assessments. 

COVID 19 Care in the Community - Assessment

$103.50 (incl. GST)
Standard Consult - Proactive Initial Assessment

$155.25 (incl. GST)
After Hours/Weekend - Proactive Initial Assessment

$43.13 (incl. GST)
Prescriber Support for Pharmacist Initiated Supply

$103.50 (incl. GST)
Standard Consult - Consultation and Testing

$155.20 (incl. GST)
After Hours/Weekend - Consultation and Testing

Eligibility

To be eligible the patient must:

• Have COVID-19 and symptoms or be a Household Contact and have symptoms; and

• Been sick within the last 5 days; and

• Meet one of the additional antiviral eligibility criteria. 

Exclusions

• Claiming is limited to one type of claim per person, per day, per practice.  

• Claims cannot be made separately for testing and proactive initial clinical assessment.

• A claim for funding cannot be made for a self-test RAT which was completed at home. 

COVID 19 Temporary Medical Exemption

$69.00 (incl. GST)
Standard Consult - Virtual Assessment

$138.00 (incl. GST)
Complex Consult -    In-Person Assessment

Key Information

• Exemptions will be limited to situations where a suitable alternative to the COVID-19 vaccine is not readily available for the individual.

• Exemptions will be for a specified time, reflecting, for example, recovery from clinical conditions or the availability of alternate vaccines. 

• The application may only be on the grounds that the person meets the specified exemption criteria. 

Potential examples of COVID-19 vaccine exemption criteria include:

• Acute illness—Recent COVID-19 infection, acute moderate to severe illness, or high dose immunosuppressives; or

• Significant adverse reaction to previous dose; or;

• Pre-existing condition impacting on vaccination.

COVID 19 Novavax Consult

$69.00 (incl. GST)

Eligibility

The Novavax COVID-19 vaccine is provided as an
alternative to the Pfizer vaccine for people who meet
the vaccine eligibility criteria and have:

• Medical contraindications to the Pfizer vaccine; or

• Not completed the primary course or had all booster
doses that they are recommended to have, and are
hesitant about receiving the Pfizer vaccine.

Key Information

• A primary course, for those over 12 years of age is 2 doses, given at least 3 weeks apart. A prescription and written consent is required. 

COVID 19 Third Dose Consult

$69.00 (incl. GST)
Standard Consult - Virtual Assessment

$138.00 (incl. GST)
Complex Consult -    In-Person Assessment

$69.00 (incl. GST)
Patient Declined Third Dose

$69.00 (incl. GST)
Patient Not Eligible for Third Dose

Eligibility

The eligibility criteria only applies to people who are severely immunocompromised:  

• Individuals with primary or acquired immunodeficiency states at the time of vaccination; 

• Individuals on, or recently on immunosuppressive therapy at the time of vaccination; 

• Individuals with chronic immune-mediated inflammatory disease who were receiving or had received immunosuppressive therapy prior to vaccination; 

• Individuals receiving long-term haemodialysis or peritoneal dialysis.

Key Information

• The third primary dose is available by prescription only and this must be provided by an authorised prescriber who has received informed, preferably written, consent from the patient.

• This third primary dose should be given 8 weeks after the second dose, but may be given 4 weeks after, depending on current or planned immunosuppressive therapies.  

COVID 19 Vaccine Consult 2nd Booster

$69.00 (incl. GST)

Eligibility

• 6 months after the first booster.

• 3 months after testing positive.